Viewing Study NCT03812393


Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-01-06 @ 8:09 AM
Study NCT ID: NCT03812393
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-12-18
First Post: 2019-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast
Sponsor: West Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module